These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23548384)

  • 1. [Characteristic of the complement system in patients with ischemic heart disease with moderate and marked hemolysis after operations with cardiopulmonary bypass].
    Chumakova SP; Urazova OI; Novitskiĭ VV; Shipulin VM; Khokhlov OA; Emel'ianova TV; Mikhaĭlova MA
    Kardiologiia; 2013; 53(2):4-9. PubMed ID: 23548384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors of intravascular hemolysis in cardiosurgical patients after cardiopulmonary bypass procedures].
    Chumakova SP; Urazova OI; Novitskiĭ VV; Shipulin VM; Mal'tseva IV; Khokhlov OA; Emel'ianova TV; Iurlova OV
    Vestn Ross Akad Med Nauk; 2012; (7):15-9. PubMed ID: 23012999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.
    Salama A; Hugo F; Heinrich D; Höge R; Müller R; Kiefel V; Mueller-Eckhardt C; Bhakdi S
    N Engl J Med; 1988 Feb; 318(7):408-14. PubMed ID: 3340119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement system is activated in a biphasic pattern after coronary artery bypass grafting.
    Hoedemaekers C; van Deuren M; Sprong T; Pickkers P; Mollnes TE; Klasen I; van der Hoeven J
    Ann Thorac Surg; 2010 Mar; 89(3):710-6. PubMed ID: 20172115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calprotectin and complement activation during major operations with or without cardiopulmonary bypass.
    Garred P; Fosse E; Fagerhol MK; Videm V; Mollnes TE
    Ann Thorac Surg; 1993 Mar; 55(3):694-9. PubMed ID: 8452432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo.
    Videm V; Mollnes TE; Bergh K; Fosse E; Mohr B; Hagve TA; Aasen AO; Svennevig JL
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):803-9. PubMed ID: 10096977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of autogenous tissue factors in hemolysis during cardiopulmonary bypass operations.
    Ford EG; Picone AL; Baisden CE
    Ann Thorac Surg; 1993 Feb; 55(2):410-2. PubMed ID: 8431052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable degree of alternative complement pathway-mediated hemolysis in Indian visceral leishmaniasis induced by differential expression of 9-O-acetylated sialoglycans.
    Chava AK; Chatterjee M; Sharma V; Sundar S; Mandal C
    J Infect Dis; 2004 Apr; 189(7):1257-64. PubMed ID: 15031795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
    van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship of AB0- and rhesus-phenotypes of erythrocytes with expression of intra-operational hemolysis in cardio-surgical patients].
    Chumakova SP; Urazova OI; Novitskiĭ VV; Shipulin VM; Khokhlov OA; Mal'tseva IV; Emel'ianova TV; Korchagina MV
    Klin Lab Diagn; 2013 Jan; (1):40-2. PubMed ID: 23807994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is cardiopulmonary bypass still the cause of cognitive dysfunction after cardiac operations?
    Taggart DP; Browne SM; Halligan PW; Wade DT
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):414-20; discussion 420-1. PubMed ID: 10469952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery.
    Baksaas ST; Flom-Halvorsen HI; Ovrum E; Videm V; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):107-17. PubMed ID: 10338322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement.
    Okada N; Harada R; Fujita T; Okada H
    J Immunol; 1989 Oct; 143(7):2262-6. PubMed ID: 2476502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.
    Mack MJ; Pfister A; Bachand D; Emery R; Magee MJ; Connolly M; Subramanian V
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):167-73. PubMed ID: 14752427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary bypass and activation of antithrombotic plasma protein C.
    Petäjä J; Pesonen E; Fernández JA; Vento AE; Rämö OJ; Griffin JH
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):422-9; discussion 429-31. PubMed ID: 10469954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolysis at different vacuum levels during vacuum-assisted venous drainage: a prospective randomized clinical trial.
    Goksedef D; Omeroglu SN; Balkanay OO; Denli Yalvac ES; Talas Z; Albayrak A; Ipek G
    Thorac Cardiovasc Surg; 2012 Jun; 60(4):262-8. PubMed ID: 21789761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.
    Simpson RJ; Florida-James GD; Whyte GP; Middleton N; Shave R; George K; Guy K
    Eur J Appl Physiol; 2007 Jan; 99(2):201-4. PubMed ID: 17089158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.